Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

12.69USD
1 Aug 2013
Price Change (% chg)

$1.48 (+13.20%)
Prev Close
$11.21
Open
$11.33
Day's High
$12.77
Day's Low
$11.26
Volume
759,439
Avg. Vol
301,445
52-wk High
$12.94
52-wk Low
$5.66

NKTR.OQ

Chart for NKTR.OQ

About

Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is consisted of early to late stage drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and... (more)

Overall

Beta: 0.65
Market Cap (Mil.): $1,295.01
Shares Outstanding (Mil.): 115.52
Dividend: --
Yield (%): --

Financials

  NKTR.OQ Industry Sector
P/E (TTM): -- 47.13 37.76
EPS (TTM): -1.62 -- --
ROI: -47.12 -2.58 18.76
ROE: -232.47 -2.66 19.59
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks